Please kindly note that if the new research ethics study has a plan to apply for clinical trial approval from the National Medical Products Administration (NMPA) in the People’s Republic of China, all applicants are required to inform the Joint CUHK-NTEC CREC by replying the acknowledgement email. If CUHK-NTEC CREC didn’t get your response, the application will be regarded as a non-NMPA study.
